Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2001-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Colony-stimulating factors may increase the number of immune cells found in bone
marrow or peripheral blood and may help a person's immune system recover from the side
effects of chemotherapy.
PURPOSE: Randomized phase II trial to compare the effectiveness of filgrastim-SD/01 with that
of filgrastim to relieve the neutropenia following combination chemotherapy in patients who
have non-Hodgkin's lymphoma.